Metabolic syndrome increases the risk of all-cause mortality, cardiovascular mortality and cardiovascular events in patients with cardiovascular disease (CVD). This study assessed the predictors of metabolic syndrome, both its incidence and resolution in a cohort of cardiac rehabilitation program graduates. Methods. A total of 154 and 80 participants without and with metabolic syndrome respecti...

Metabolic syndrome is a compilation of symptoms including central obesity, insulin resistance, dyslipidemia, and hypertension. Initially used to predict cardiovascular disease, it is now clear that the molecular and physiologic abnormalities seen in metabolic syndrome extend well beyond the cardiovascular system. Growing evidence has linked metabolic syndrome and its individual symptoms to the ...

background: polycystic ovary syndrome (pcos) causes an increased risk of metabolic cardiovascular syndrome. also, cystatin c serum levels are associated with the risk of cardiovascular events in metabolic syndrome patients. objective: to investigate the relationship between cystatin c in pcos patients. materials and methods: 35 women with pcos were compared to 35 women with healthy matched age ...

OBJECTIVE The aim of this study was to assess in an 11-year survival follow-up of a population-based cohort of type 2 diabetes the predictive role of World Health Organization-defined metabolic syndrome, independent of conventional cardiovascular risk factors. RESEARCH DESIGN AND METHODS During the follow-up (1991-2001), 1,565 patients were regularly examined with centralized measurements of ...

Subjects with metabolic syndrome--a constellation of cardiovascular risk factors of which central obesity and insulin resistance are the most characteristic--are at increased risk for developing diabetes mellitus and cardiovascular disease. In these subjects, abdominal adipose tissue is a source of inflammatory cytokines such as tumor necrosis factor-alpha, known to promote insulin resistance. ...

The significance of metabolic syndrome in association with cardiovascular diseases has triggered extensive debate, and the number of medical reports in this area is increasing exponentially. One of several controversial points is whether the 5 components (elevated glucose, higher triglyceride, lowered highdensity lipoprotein [HDL] cholesterol, central obesity, and hypertension) of metabolic syn...

M etabolic syndrome increases risk for cardiovascular disease (1,2). The diagnosis of metabolic syndrome in patients might hold promise for enhanced prevention of cardiovascular disease. Currently, there is no consensus on the diagnosis of metabolic syndrome in children and adolescents, with variable prevalence of metabolic syndrome from 4.2 to 32% in several populations (3–5). The highest rate...

Background and Objectives: There is convincing evidence that subjects concomitantly affected by type 2 diabetes (T2D) and metabolic syndrome (MeS) are at greater risk for cardiovascular disease (CVD). Many metabolic derangements in T2D might be attributed to poor vitamin D status. The purpose of this study was to investigate the associations among vitamin D status, MeS and glycemic status in su...